Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference14 articles.
1. Screening for obstructive sleep apnea among individuals with severe mental illness at a primary care clinic;Alam;Gen Hosp Psychiatry,2012
2. Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: a case report and review of the literature;Ferrazzi;Exp Ther Med,2016
3. Dermatological side effects of epidermal growth factor receptor inhibitors: ‘PRIDE’ Complex;Madke;Indian J Dermatol,2014
4. The baboon syndrome: systemically-induced allergic contact dermatitis*;Andersen;Contact Dermatitis,1984
5. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?;Häusermann;Contact Dermatitis,2004
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Skin microbial dysbiosis is a characteristic of systemic drug-related intertriginous and flexural exanthema-like lesions induced by EGFR inhibitor;Heliyon;2023-11
2. Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?;Cutis;2023-01-01
3. Symmetrical drug-related intertriginous and flexural exanthema and acneiform eruption in a patient with metastatic colorectal cancer treated with cetuximab;CLIN CANCER INVESTIG;2021
4. Symmetric drug‐related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature;Journal of Cutaneous Pathology;2021-07-08
5. Symmetrical drug-related intertriginous and flexural exanthema and acneiform eruption in a patient with metastatic colorectal cancer treated with cetuximab;Clinical Cancer Investigation Journal;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3